Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this insightful discussion, Psych Congress Faculty Member Timothy Wilens, MD, dissects the challenges clinicians may face when diagnosing and treating common psychiatric comorbidities in individuals with ADHD.
In this insightful discussion, Psych Congress Faculty Member Timothy Wilens, MD, dissects the challenges clinicians may face when diagnosing and treating common psychiatric comorbidities in individuals with ADHD.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.